David Mehalick
2021
In 2021, David Mehalick earned a total compensation of $216.5K as Chairman, CEO and President at Coeptis Therapeutics Holdings.
Compensation breakdown
| Salary | $216,500 |
|---|---|
| Total | $216,500 |
Mehalick received $216.5K in salary, accounting for 100% of the total pay in 2021.
Rankings
In 2021, David Mehalick's compensation ranked 11,931st out of 12,415 executives tracked by ExecPay. In other words, Mehalick earned more than 3.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,931 out of 12,415 | 4th |
Division Manufacturing | 5,274 out of 5,505 | 4th |
Major group Chemicals And Allied Products | 2,299 out of 2,375 | 3rd |
Industry group Drugs | 2,038 out of 2,096 | 3rd |
Industry Biological Products, Except Diagnostic Substances | 439 out of 449 | 2nd |
Source: SEC filing on November 17, 2023.
Mehalick's colleagues
We found two more compensation records of executives who worked with David Mehalick at Coeptis Therapeutics Holdings in 2021.